Is it perimenopause ... or something else? A new wearable is helping women demystify symptoms like hot flashes and brain fog.
Why is it suddenly harder to find the right word or remember the name of the restaurant you used to go to? When did sleeping through the night become such a rarity? And what's up with that shoulder pain that came out of nowhere? Welcome to perimenopause — the transition period that kicks off years before you officially reach menopause. While hot flashes and night sweats steal most of the spotlight, there are many subtler and seemingly random symptoms that can crop up (itchy ears, anyone?). It can leave women feeling blindsided and lost, like they're navigating an ever-shifting landscape without a compass or a map.
A 2022 survey of nearly 950 perimenopausal women in the U.K. found that more than 60% said they didn't feel informed at all about this stage of life. Other than hot flashes, 'most of the women were entirely unaware of the wide array of symptoms and so did not connect them to the perimenopause,' according to the study authors.
A more recent survey of nearly 4,500 American women revealed that more than 55% of those ages 30 to 35 had symptoms that could be classified as 'moderate' or 'severe' on the Menopause Rating Scale (MRS), a common questionnaire that measures the intensity of menopause symptoms. That increased to more than 64% in women ages 36 to 40. But the researchers behind the survey found that most women don't talk to a health care professional about their symptoms until they reach their mid-50s. Many just muscle through an uncomfortable array of symptoms.
A lot of it comes down to the fact that almost no one is taught about perimenopause and menopause (and most doctors aren't adequately trained in it), so they may not know what signs to look out for and how to best manage symptoms. Technology is stepping in to fill the gap. The latest: a wearable device that's specifically designed to help women track perimenopause symptoms and figure things out sooner. It's called Peri by identifyHer, and it's a first-of-its-kind tool to help midlife women be better informed about this stage of life and their health. Here's what's behind this innovative technology, plus what menopause experts think.
The problem: Figuring out whether you're in perimenopause is like playing a guessing game — but with your health. And managing symptoms can be difficult if you don't know where to start.
By the numbers: A 2021 survey found that 44% of women were unaware of perimenopause until they started experiencing symptoms, while 46% were not expecting perimenopause when it started. A more recent survey by Ohio State Wexner Medical Center revealed that more than 60% of women believe they will reach menopause in their 40s. However, perimenopausal symptoms can start as early as your 30s, while the average age of menopause is 51, which can catch some women off guard.
The solution: Peri by identifyHer is a wearable device with a corresponding app that's designed for women in perimenopause. It was a 2025 CES Innovation Awards Honoree and is relatively simple to use.
The tool has an adhesive that sticks to your torso and collects data on everything from hot flashes and night sweats to sleep, anxiety and brain fog, sending that information to the app. It also gives personalized feedback on how to manage your specific symptoms.
Chief executive officer and cofounder Heidi Davis tells Yahoo that the device was designed with the goal of supporting women. 'There's a critical lack of support and objective data when it comes to perimenopause — a stage that affects nearly every woman yet is still poorly understood,' she says. 'Beyond helping women in the moment, Peri aims to help close the gender data gap by gathering women-specific health data. Perimenopausal symptoms can be an early signal for future health outcomes, and understanding them better is key to keeping women healthier and more productive for longer.'
Peri continuously monitors perimenopausal symptoms over time to analyze patterns and provide advice on next steps for women. 'These include tailored feedback on lifestyle around diet and exercise, feedback on hormone replacement therapy if applicable and tracking of symptoms across the cycle — helping women identify underlying causes of things like sleep disruption, e.g., is it night sweats? Anxiety?' Davis says. 'It also helps prompt more informed conversations with health care providers by offering a clear picture of what's going on.' Meaning, you can take the app's findings to your doctor to go over what you're experiencing in detail.
Doctors who treat women in perimenopause and menopause say these details can be helpful. 'Digitalized health is one of the best ways to implement health care and to truly understand a patient's progression, recovery and journey through certain medical conditions,' women's health expert Dr. Jessica Shepherd, an ob-gyn in Dallas and author of the book Generation M: Living Well in Perimenopause and Menopause, tells Yahoo. 'The hormonal shifts seen in perimenopause and menopause are able to be tracked with a device such as this, which is valuable, especially since the journey of this transition is very hard to contextualize to a group of women.'
Dr. Lauren Streicher, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, tells Yahoo that a device like this can help women identify symptoms they may not realize are from perimenopause and share them with their health care provider. 'Women are not aware of all of their hot flashes,' she says, pointing out that these can happen overnight when women are sleeping. 'There is value in knowing how many hot flashes you're actually having and whether whatever you're doing to try to make them go away is working,' Streicher says.
That actually matters more than just knowing your health stats. 'There is a correlation between the severity of symptoms in perimenopause, such as hot flashes and night sweats, that can have a direct link to future health implications, such as heart disease, neurodegenerative diseases and overall quality of life,' Shepherd says. 'There is data that shows the increased severity of either hot flashes or night sweats was associated with a higher risk of cardiovascular disease.'
While some experts say the wearable device is useful, Dr. Mary Jane Minkin, a clinical professor of obstetrics and gynecology and reproductive sciences at Yale School of Medicine and founder of Madame Ovary, says you don't need it to help you navigate perimenopause comfortably. 'As a general rule, things that are helpful for perimenopausal symptoms are also very good for medical health in general: getting lots of exercise (both aerobic and strength training) and eating a healthy diet — some varieties of a Mediterranean diet are good for most women,' Minkin tells Yahoo. 'Stopping smoking and avoiding excess alcohol — I discourage women from drinking more than one drink a day — are also good to minimize perimenopausal symptoms.'
Minkin says it's also crucial to find a health care provider who understands perimenopause. (She recommends focusing on providers who are members of the Menopause Society and Menopause Society-certified practitioners.)
Davis says she hopes her tool can help women make sense of what's happening to their bodies at this stage of life. 'Symptoms [of perimenopause] are often dismissed or misattributed, and women are left to manage on their own,' she says. 'There's a massive opportunity to bring clarity, support and personalization to this experience.'
Preorders for Peri open in September 2025, and the first devices will ship in October.
Solve the daily Crossword

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Dr. Javad Sajan Does First Facial-Feminization with Simultaneous Hair Transplant Procedure
Seattle Plastic Surgeon Performs Nation's First Combined Facial Feminization & Hair Transplant Surgery SEATTLE, WA / / August 5, 2025 / Dr. Javad Sajan, a top Seattle plastic surgeon and founder of Allure Esthetic Plastic Surgery, has made medical history in the U.S. by performing the nation's first facial feminization surgery (FFS) combined with hair transplant in a single operative session. The milestone procedure was performed on Ember Norman and is featured on offering a detailed look at the surgical planning, technique, and outcomes. The entire surgery, including the hair transplant, qualified for coverage under Norman's gender‑affirming insurance plan. As part of a full facial feminization surgery, Dr. Javad Sajan performed a carefully planned combination of skeletal and soft tissue procedures to transform the patient's facial structure and features. The surgery began with upper facial bone contouring, including frontal bone and orbital bone reduction, and a frontal sinus setback to soften and feminize the upper third of the face. A follicular unit transplant of 1,000 grafts was performed to feminize the hairline. To further feminize the upper face, Dr. Sajan performed a brow lift, elevating the brow position for a more open and feminine expression. In the midface, a mid-facelift and rhinoplasty were performed to enhance facial harmony and refine nasal shape and projection. For the lower face, Dr. Sajan completed a lip lift to shorten the philtrum and improve lip aesthetics. This was followed by chin bone reduction and jaw bone reduction to narrow and sculpt the lower facial contour. This comprehensive transformation reflects the precision and artistry involved in advanced facial feminization surgery. The full surgical journey and before-and-after results can be viewed here. These combined procedures eliminate the need for a second surgery, making the healing process easier and more efficient. Key benefits of this approach include: Single anesthesia event and one recovery timeline A lower and more feminine hairline Minimal scarring Who is an ideal candidate for a same-day FFS+ hair transplant? Ideal candidates for simultaneous FFS and hair transplant surgery include healthy transgender or non-binary patients who are medically cleared for general anesthesia, have realistic expectations, and maintain stable hormone levels for at least six months. Is combining the procedures safe? Combining both procedures in a single session is generally safe; however, all surgery and anesthesia have risks. It eliminates the need for a second anesthesia event, minimizes cumulative swelling, and avoids re-entering previously operated areas, such as a freshly feminized forehead, during a later surgery. How long does the surgery take? The combined procedure typically takes 6 to 12 hours, depending on the extent of facial bone reshaping and the number of hair grafts required. About Dr. Javad Sajan and Allure Esthetic Plastic Surgery: Dr. Javad Sajan is a renowned Seattle-based plastic surgeon, known for his leadership in gender-affirming and facial cosmetic surgery. At Allure Esthetic, Dr. Sajan and his team blend advanced techniques with personalized care to deliver exceptional results. Media Contact:Allure Esthetic Plastic SurgeryPhone: 206-209-0988Website: info@ SOURCE: RealDrSeattle View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Why Hims & Hers Health Stock Just Dropped
Key Points Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street wanted more. Hims & Hers also reported negative free cash flow for the first half of the year. 10 stocks we like better than Hims & Hers Health › Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling today, down 6.7% through 10:55 a.m. ET after missing in its second-quarter earnings report last night, on both the top and bottom lines. Heading into the report, analysts forecast Hims & Hers would earn $0.23 per share on $552 million in sales -- but Hims & Hers earned only $0.17 per share, and sales were less than $545 million. Hims & Hers' Q2 earnings But was the news really as bad as it seems? After all, while Hims & Hers "missed" on sales, it did still grow sales 73% year over year. That was twice as fast as it grew subscribers, too (31%), indicating that not only are more customers signing up for the company's services, but they're buying more, too. And while Hims & Hers missed on earnings, too, those earnings per share nearly tripled year over year. Really, the only "bad" number I see in the report concerns free cash flow (FCF). Through the first half of this year, Hims & Hers grew its operating cash flow only 13%, to $90 million (within a couple of percentage points of reported net income). However, the company spent massively on capital expenditures -- more than $100 million -- resulting in negative FCF for the first half of 2025. Investors seem unsure what to make of the news. At one point this morning, the stock had recovered all its losses, and even turned green, before falling back into the red. Is Hims & Hers stock a sell? So how should investors react to this conflicting news? At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more expensive when valued on FCF -- about 103 times. These might be acceptable valuations if earnings were to continue tripling year after year. In fact, though, analysts see profits growing only 13% this year, and perhaps 57% next. For the time being, Hims & Hers stock remains too expensive to buy. Should you buy stock in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Why Hims & Hers Health Stock Just Dropped was originally published by The Motley Fool
Yahoo
24 minutes ago
- Yahoo
Multiple infections linked to raw milk consumption in Florida, health officials say
The Florida Department of Health is investigating an outbreak of infections linked to drinking unpasteurized milk, officials said this week. The health department issued a bulletin Monday, reporting that 21 people who consumed raw milk from the same farm had been infected with campylobacter and E. coli, with seven of those patients requiring hospitalization. Of the 21 cases, six were children under the age of 10. "Severe complications have been reported for at least two cases," officials said. The health department did not name the farm that produced the raw milk but confirmed the ingredient was linked to the cases. It is illegal to sell raw milk for human consumption in Florida. Raw milk can legally be sold for non-human consumption "as pet or animal food," the health department stated, because it doesn't undergo the same sanitary regulations and can be a source of foodborne illness. "Due to continued recent cases of Campylobacter and Shiga toxin-producing E. coli (STEC) infections linked to a particular farm, the Florida Department of Health is providing information to assist Floridians in making informed decisions about their health," Monday's health alert stated. "Sanitation practices in this farm are of particular concern due to the number of cases." This is a developing story. Please check back for more details. Solve the daily Crossword